Etiometry

Boston, MA All United States companies → — Founded 2010

Clinical AI Platform Specialty-Focused AI

Anesthesiology Critical Care Emergency Medicine

Clinical Decision Support & Reference Triage & ER/ICU AI

Later Stage VC / Series A — $24.6M

Website Claim this company

Products

Etiometry

Clinical Decision Support & Reference

Etiometry’s platform delivers deep physiologic insights and supports the automation of hospital defined clinical pathways—enabling clinicians to make timely decisions and actions that may improve outcomes, reduce costs, and ease the burden on care teams.

Contact for pricing

See all 1 product →

About Etiometry

Etiometry is a leading healthcare AI company specializing in clinical intelligence and decision-support software for high-acuity care settings, primarily intensive care units (ICUs). Their platform aggregates real-time physiological data from various bedside devices and laboratory systems, providing clinicians with a comprehensive, time-sequenced dashboard. It leverages advanced analytics and proprietary AI-powered risk algorithms, such as the Inadequate Oxygen Delivery Index (IDO2) and Inadequate Ventilation of CO2 (IVCO2), to identify subtle changes in patient conditions and anticipate deterioration.

For physicians, the Etiometry Platform is designed to facilitate data-driven, proactive decision-making, supporting both care escalation and de-escalation. It aims to standardize care through automated clinical pathways and workflows, improve patient outcomes by enabling earlier intervention, and enhance clinical efficiency while potentially lowering costs. The company has received multiple FDA clearances, including a recent one for automating hospital-specific cardiogenic shock classification and tracking, and its solutions are utilized by top academic medical centers and children’s hospitals, with expanding adoption in adult ICUs, operating rooms, and emergency departments.

Focus Areas

Clinical Decision Support AI-driven Clinical Intelligence Critical Care Intensive Care Units (ICUs) Hemodynamic Management Respiratory Management Patient Deterioration Quality Improvement Clinical Pathway Automation Real-time Physiologic Data Integration and Visualization EHR and Bedside Device Interoperability Software-as-a-Medical-Device Regulatory Clearance Cybersecurity Cardiogenic Shock Management

Business Intelligence

Key Investors	Shamrock Holdings, Shepherd Kaplan Krochuk (SKK 9i Ventures), Escalate Capital Partners, United States Department of War, U.S. Department of Health and Human Services
Partnerships	Children's Hospital of Alabama, Boston Children's Hospital, Children's National Hospital, Washington University School of Medicine (for studies), Radiometer America (distribution), Terumo Cardiovascular (strategic collaboration), multiple enterprise agreements with prominent healthcare systems in the Midwest and Mountain regions of the U.S., international markets
Technology	Etiometry Platform (T3 Platform), Data Aggregation and Visualization, Risk Analytics Engine (RAE) with Bayesian models (IDO2, IVCO2, ACD, HLA), high-resolution waveform data integration, web-based/cloud-deployable architecture, FHIR and EHR integration, AI/machine learning risk algorithms, real-time physiologic data streaming and ingestion, data de-identification and normalization pipelines, clinical visualization and dashboarding, automated workflow/clinical pathway engines, unit surveillance and triage dashboards.
FDA Clearances	11 cleared products (estimated)

What Physicians Need to Know

Clinical Decision Support

Etiometry specializes in providing AI-driven clinical decision support software specifically designed for high-acuity environments like Intensive Care Units (ICUs).

AI-driven Clinical Intelligence

Their platform leverages artificial intelligence and machine learning algorithms to offer deep physiologic insights and continuous, contextual analysis of patient data.

Critical Care & ICU Focus

The core of Etiometry's offering is an end-to-end clinical data software solution for the collection, analysis, visualization, and archiving of ICU clinical data, used in over 175 ICUs across 50+ hospitals.

Hemodynamic & Respiratory Management

The platform supports personalized hemodynamic and respiratory care strategies, including specific risk indices and automated pathways for conditions like ARDS and ventilator weaning.

Patient Deterioration & Risk Analytics

Etiometry provides FDA-cleared adjunctive risk indices (e.g., IDO2, IVCO2, HLA, ACD) to anticipate and detect early signs of patient deterioration, enabling proactive interventions.

Quality Improvement & Research

The platform includes a Quality Improvement Application for automated reporting, event reviews, and provides de-identified longitudinal datasets to power continuous improvements and clinical research.

Clinical Pathway Automation

Etiometry enables the automation of hospital-defined clinical pathways, driving consistent and timely adherence to care protocols, and reducing care variability across all ICU segments.

Real-time Data Integration & Visualization

It aggregates high-fidelity, continuous physiologic data from monitoring systems, peripheral devices, EHRs, labs, and medications into a single, trended, and easy-to-interpret display.

EHR & Bedside Device Interoperability

The platform seamlessly integrates with existing EHRs (e.g., Cerner, Epic) and bedside devices without requiring custom coding or HL7 interfaces, presenting a holistic patient view.

Software-as-a-Medical-Device Regulatory Clearance

Etiometry holds multiple FDA clearances, including for its physiologic risk algorithms and a first-ever automated tool for hospital-specific cardiogenic shock classification and tracking.

Cardiogenic Shock Management

They offer an FDA-cleared tool for automated cardiogenic shock classification and tracking, combining physiologic data with EHR, lab, and device inputs to provide continuous patient status based on SCAI guidelines.

Physician Tip

Etiometry stands out for physicians by significantly reducing cognitive load and burnout through its ability to consolidate vast amounts of real-time patient data into one intuitive, trended display, making critical insights readily accessible. This enables earlier detection of patient deterioration via FDA-cleared AI algorithms, supporting timely and informed interventions. The platform facilitates both standardized and personalized care through customizable clinical pathway automation, ensuring adherence to hospital protocols while allowing for individual patient needs. It enhances communication during handoffs and rounds by providing a shared, holistic view of the patient's condition, improving team collaboration. For newer clinicians, it builds confidence by offering immediate access to comprehensive, trended data, helping them understand and articulate patient status more effectively. Etiometry is not an alarm system but an adjunctive decision support tool, augmenting clinical judgment with actionable insights and informational flags. Furthermore, it supports quality improvement initiatives and clinical research by providing tools for event review and access to de-identified datasets.

Etiometry's platform is designed for seamless integration with existing hospital IT infrastructure. It integrates deeply with Electronic Health Records (EHRs), including major systems like Cerner and Epic, and various bedside monitoring devices, lab information systems, and peripheral devices. The platform supports Single Sign-On (SSO) within EHRs for convenient access. Clinicians can access the platform via persistent bedside displays, workstations on wheels (WOW), central ICU command centers, or remotely through hospital-approved VPNs, ensuring flexibility and accessibility within existing workflows.

At a glance

Founded 2010

HQ Boston, MA · United States

Team size 56

CEO Shane Cooke

Funding Later Stage VC / Series A — $24.6M

FDA clearances 11 (estimated)

Products 1

Visit site

Products by Etiometry

1 product in the directory

Etiometry

Clinical Decision Support & Reference

Contact for pricing

What the Web Says

Etiometry is generally viewed as a company with a strong mission to improve patient care through data analytics, particularly in critical care settings. Their software is appreciated for its ability to integrate various data points and provide actionable insights. As an employer, they are seen as having a positive culture, though some challenges related to growth and workload are mentioned.

Overall: Positive

Strengths

Strong mission-driven company focused on patient outcomes.
Innovative product that integrates diverse patient data for critical care.
Positive company culture with supportive colleagues.
Opportunities for professional growth and learning.
Leadership is generally well-regarded and transparent.
Impactful work that contributes to saving lives.

Limitations

Workload can be demanding due to rapid growth and small teams.
Some users report a steep learning curve for the product.
Specific product features or integrations may need improvement.
Compensation might not always be competitive with larger tech companies.
Potential for burnout if work-life balance isn't carefully managed.
Limited public reviews make it hard to get a comprehensive view.

Based on reviews from: Glassdoor, LinkedIn (employee posts and profiles), Healthcare IT News (mentions/articles), Company website (for mission/values), Various industry publications and awards

Last updated: 2026-07-23

Videos

News, demos, and interviews about Etiometry.

Loading videos...

Videos load interactively. If none appear, search YouTube for Etiometry →

View all on YouTube

Press & Coverage

Etiometry

Etiometry Receives a First-Ever FDA Clearance for Automating Hospital-Specific Cardiogenic Shock Classification and Tracking

Etiometry announced FDA clearance (K254066) for its Cardiogenic Shock Tool, the first solution to automate hospital-specific cardiogenic shock classification and tracking using physiologic monitoring data. This tool aims to improve early identification and management of cardiogenic shock.

2026-04

Etiometry

Etiometry Named Top Clinical Intelligence Platform of 2026

Etiometry was recognized as the Top Clinical Intelligence Platform of 2026 by Healthcare Tech Outlook, highlighting its AI-driven clinical intelligence platform.

2026-02

Etiometry

Etiometry Expands Evidence Base with New Adult Data Demonstrating Clinical Value Across Critical Care Settings

Etiometry announced the expansion of its clinical evidence base in adult critical care with new data presented at the 2026 Society of Thoracic Surgeons Annual Meeting. The study demonstrated the platform's ability to identify patient-specific risk and support improved resource utilization in adult patients.

2026-02

Etiometry

Etiometry's AI Platform Drives Measurable Outcomes as Hospitals Face Unprecedented Pressures

Etiometry celebrated significant achievements in 2025, including platform advancements, increased hospital installations, its 10th FDA clearance, and an award for 'Best in Class - AI in Patient Care'. The company aims to continue transforming critical care in 2026.

2026-01

Etiometry

PAS 2026 Abstract Reports Association Between IVCO2 Index Implementation and Blood Gas Measurement Frequency in NICU Patients

Etiometry announced a retrospective analysis presented at the Pediatric Academic Societies (PAS) 2026 Meeting, showing a 10% reduction in blood gas measurement frequency following the clinical adoption of its IVCO2 Index in a Level IV NICU.

2026-04

Etiometry

Multicenter Study Demonstrates 29% Reduction in Vasoactive Infusion Time with Use of Etiometry's AI Powered Clinical Intelligence Platform

A multicenter clinical trial published in Critical Care Medicine showed that Etiometry's Clinical Intelligence Platform, specifically its IDO2 Index, was associated with a 29% reduction in the duration of vasoactive and inotropic infusions after pediatric cardiac surgery.

2025-06

Etiometry

Boston Children's Hospital Multi-center Study Finds Etiometry's Risk Analytics Algorithms May Help Assess Extubation Failure Following Congenital Cardiac Surgery

A multi-center study published in Pediatric Critical Care Medicine, led by Boston Children's Hospital, found that Etiometry's FDA-cleared IDO2 and IVCO2 physiologic risk analytics were associated with an increased risk of extubation failure in neonates after congenital cardiac surgery.

2025-05

Etiometry

Etiometry Achieves 10th FDA Clearance for Critical Care Platform

Etiometry received its 10th FDA clearance for its critical care platform, emphasizing its commitment to cybersecurity and regulatory standards in clinical decision support software.

2025-02

Frequently Asked Questions

What is the Etiometry Platform and how does it support clinical decision-making in critical care?

The Etiometry Platform is an AI-driven clinical intelligence solution designed for ICUs that aggregates real-time physiologic, lab, and EHR data into a unified view. It computes FDA-cleared risk indices, such as IDO2 and IVCO2, to help clinicians identify early signs of patient deterioration and support timely, data-driven decisions for hemodynamic and respiratory management.

How does Etiometry ensure regulatory compliance and data security for its Software-as-a-Medical-Device?

Etiometry holds multiple FDA 510(k) clearances, including its most recent clearances that incorporate enhanced cybersecurity compliant with FDA Section 524B guidelines. The platform also has CE marking under EU MDR and Health Canada licensing, ensuring fortified data protection and secure integration with medical devices and EHRs, while being designed to satisfy HIPAA requirements.

Can Etiometry's platform integrate with our existing EHR and bedside monitoring systems?

Yes, the Etiometry Platform is designed for seamless interoperability, integrating real-time data from patient monitors, peripheral devices, and EHRs, including HL7 and FHIR compatibility. Clinicians can access the web-based platform via bedside displays, workstations, VPN, or through single sign-on within their existing EHR systems.

What specific clinical outcomes and quality improvements can we expect from implementing Etiometry?

Hospitals utilizing Etiometry have reported significant improvements, including up to a 41% reduction in ICU readmissions, a 36% reduction in ICU length of stay, and a 30% reduction in ventilation time. The platform also supports quality improvement initiatives and clinical research through its data aggregation and reporting capabilities.

How does Etiometry address the challenges of Cardiogenic Shock Management?

Etiometry recently received FDA clearance for its Cardiogenic Shock Tool, the first automated solution for hospital-specific classification and tracking of cardiogenic shock. This tool integrates high-fidelity physiologic data with EHRs and lab inputs to provide continuous, standardized situational awareness based on SCAI guidelines, aiding early identification and coordinated care.

What kind of implementation and ongoing support does Etiometry provide?

Etiometry offers a comprehensive implementation plan that aligns with a hospital's IT infrastructure, with their team handling necessary customization and integration. They also provide an ongoing adoption program at no additional cost, which includes platform enhancements, support for infrastructure updates, and clinical workflow integration and training.

What is Etiometry's company stability and market presence?

Founded in 2010, Etiometry is a privately held company recognized as a leader in AI-driven clinical intelligence, with its platform used in over 175 ICUs across more than 50 hospitals globally. The company has demonstrated strong commercial momentum, expanding its footprint and partnerships in leading healthcare institutions worldwide.

Related Companies

Suggest an Edit →